US 9732359
Replication-competent adenoviral vectors
granted A61KA61K2039/5256A61K2039/575
Quick answer
US patent 9732359 (Replication-competent adenoviral vectors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/5256, A61K2039/575, A61K39/21